Skip to main navigation Skip to search Skip to main content

Intact Proteoform Analysis by Capillary Electrophoresis–Mass Spectrometry. Are We There Yet?

  • Noah Gould
  • , Qianjie Wang
  • , Jeffrey N. Agar
  • , Jennifer S. Brodbelt
  • , Daoyang Chen
  • , Kellye A. Cupp-Sutton
  • , Elena Domínguez-Vega
  • , Fei Fang
  • , Marianne Fillet
  • , Matthew S. Fischer
  • , Attila Gaspar
  • , Ying Ge
  • , Marie Jia Gou
  • , Michal Greguš
  • , Christoph Gstöttner
  • , Narmin Hamidli
  • , Amanda Helms
  • , Md Amin Hossain
  • , Kyle J. Juetten
  • , Neil L. Kelleher
  • Tobias Kraus, Eli J. Larson, J. Scott Mellors, Cynthia Nagy, Christian Neusüß, Erin A. Redman, Jasmin Schairer, Si Wu, Tian Xu, Zhitao Zhao, Guijie Zhu, Alexander R. Ivanov*, Kevin Jooß*, Liangliang Sun*
*Corresponding author for this work

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

Mass spectrometry (MS)-based top–down proteomics (TDP) has emerged as a powerful tool for characterizing proteoforms to advance both fundamental and translational research. TDP requires high-efficiency liquid-phase separation, high-resolution MS, and tandem MS. Capillary zone electrophoresis (CZE)-MS has been proposed as a promising analytical technique for protein analysis decades ago because of its unique and valuable features, including high separation efficiency and high detection sensitivity. However, CZE-MS has not been widely adopted by the proteomics community, mainly due to concerns with its robustness and reproducibility. Here, we hypothesized that CZE-MS is sufficiently robust and reproducible for broad adoption due to the continued efforts of the community over the last three decades. In this work, for the first time, research teams from around the world validated the robustness, repeatability, and reproducibility of CZE-MS for TDP in both simple and complex model proteoform mixtures employing a full spectrum of commercially available capillary electrophoresis (CE)-MS interfaces, instrumentation, and compared CZE-MS performance with state-of-the-art liquid chromatography (LC)-MS methods. This study offers the research community an informative resource of ready-to-use experimental CE-MS techniques and a better understanding of the CZE-MS approach and its potential in TDP, accelerating the broad adoption of CZE-MS in proteoform research.

Original languageEnglish
Article numbere18366
Number of pages15
JournalAngewandte Chemie - International Edition
Volume65
Issue number5
Early online date18 Dec 2025
DOIs
Publication statusPublished - 28 Jan 2026

Bibliographical note

Publisher Copyright:
© 2025 The Author(s). Angewandte Chemie International Edition published by Wiley-VCH GmbH.

Funding

The authors are grateful to all members of the Board of Directors of the Consortium for Top–Down Proteomics for initiating the study and for valuable discussions. A.R.I. was in part supported by the National Institutes of Health, and specifically, the National Institute of General Medical Sciences under award number NIH NIGMS R35GM136421 (A.R.I.), 5P41GM128577 (A.R.I., with Prof. V. Wysocki as PI), R41GM156145 (A.R.I.), and the National Cancer Institute under award number NCI R01CA218500 (A.R.I.). L.S. was supported by the National Institute of General Medical Sciences through grant R35GM153479 (L.S.) and the National Cancer Institute (NCI) through the grant R01CA247863 (L.S.). J.B. would like to acknowledge the National Institutes of Health under award number NIH R35GM139658 (J.B.). E.D‐V. would like to acknowledge support from the LUMC fellowship (2020). A.G. would like to thank the National Research, Development and Innovation Office, Hungary (K124134). Y.G. would like to acknowledge National Institute of Health (NIH) R01 GM117058 and HL109810 (Y.G.). S.W. would like to acknowledge the National Institute of Health (NIH) under award numbers NIAID R01AI141625 and NIAID 2U19AI062629, the Oklahoma Center for Advancement of Science and Technology (OCAST) under award number HR23‐169, and S.W. would like to thank the University of Alabama for the support received from the startup fund.

FundersFunder number
University of Alabama
Leids Universitair Medisch Centrum
National Institutes of Health
National Cancer InstituteR35GM153479, R35GM139658, NCI R01CA218500, R01CA247863
National Institute of Allergy and Infectious DiseasesR01AI141625, 2U19AI062629
Oklahoma Center for the Advancement of Science and TechnologyHR23‐169
National Institute of General Medical Sciences5P41GM128577, R41GM156145, R35GM136421

    Keywords

    • Analytical methods
    • Electrophoresis
    • Mass spectrometry
    • Proteomics

    Fingerprint

    Dive into the research topics of 'Intact Proteoform Analysis by Capillary Electrophoresis–Mass Spectrometry. Are We There Yet?'. Together they form a unique fingerprint.

    Cite this